SHILPA MEDICARE LTD (SHILPAMED) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company’s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and…
Shilpa Medicare Ltd
SHILPAMED
Market Cap₹11,945Cr.
Current Price₹611
High / Low₹650/260
Stock P/E103
Book Value₹139
Dividend Yield0.08%
ROCE4.91%
ROE4.27%
Face Value₹1.00
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company’s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML’s wholly owned subsidiary Shilpa Therapeutics.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 13:20:05